Biogen Inc. buy Wells Fargo & Company
Start price
07.08.23
/
50%
€244.00
Target price
07.08.24
€311.86
Performance (%)
-19.96%
Price
26.04.24
€195.30
Summary
This prediction is currently active. The price of Biogen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.96%. This prediction currently runs until 07.08.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 7.014% | 7.014% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Wells Fargo & Company from $350.00 to $343.00. They now have an "overweight" rating on the stock.
Ratings data for BIIB provided by MarketBeat